Members of the World Health Organization reached a landmark agreement on Wednesday on how to learn from COVID-19, which killed millions of people in 2020-22, and prepare the world for future pandemics ...

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, April 14, 2025 /PRNewswire/ -- Equity Insider News Commentary - Routine medical ...

If mass layoffs at Spark Therapeutics ultimately lead the firm to consolidate its space, University City could see a surge in ...

Former Spark CEO Jeff Marrazzo said hundred of employees caught up in the waves of layoffs will be aided by a network of former Spark colleagues who have gone on to lead new companies.

Cell and gene therapy standout Spark Therapeutics is undergoing its second shakeup in a month, with plans to lay off about half of its workforce. Several hundred people will be affected. A WARN notice ...

QKS Group has named Doxee as a SPARK leader in their analysis of the SPARK Matrix™: Customer Communication Management (CCM), ...

QKS Group announced today that it has named Zimperium as a 2025 technology leader in the SPARK Matrixtm: In-App Protection, 2025. Ayush Patidar, Analyst at QKS Group, states, "Zimperium MAPS delivers ...

Earlier in his career, Mr. Goodman also worked in business development at Spark Therapeutics and served as a management consultant at Easton Associates, a boutique life sciences consultancy. He holds ...

Barclays views the recent pullback in shares of Relay Therapeutics (RLAY) as a buying opportunity. The firm says Relay stands out in its ...

Earlier in his career, Mr. Goodman also worked in business development at Spark Therapeutics and served as a management consultant at Easton Associates, a boutique life sciences consultancy.

The Swiss pharma has reached a deal to buy Spark in an all-cash transaction at a price of $114.50 per share, a premium of 122% to the US company's closing price on Friday evening.